K2O–Al2O3–SiO2 glass–ceramics, despite their structural advantages, typically exhibit limited intrinsic bioactivity due to the stabilizing effect of Al2O3. In this study, a synergistic HCl–CaCl2 surface-activation strategy is proposed to overcome this limitation and to induce controlled hydroxyapatite (HAp) formation. The glass–ceramics, consisting of boromuscovite and boromullite phases within a borosilicate–aluminosilicate network, were systematically surface modified using single-step and sequential chemical treatments. While single-step treatments failed to trigger apatite nucleation even after prolonged immersion in simulated body fluid (SBF), the combined HCl–CaCl2 treatment enabled rapid and selective formation of an apatite-like Ca–P layer. SEM–EDS and XPS analyses confirmed homogeneous Ca–P deposition and the progressive evolution toward calcium-deficient apatite compositions. Mechanistically, the enhanced bioactivity arises from the synergistic interplay between surface hydroxylation (Si–OH formation) and calcium enrichment, which lowers the nucleation barrier and promotes electrostatically driven Ca–P cluster formation. Furthermore, MTT results demonstrate excellent cytocompatibility at low to moderate extract concentrations, governed by controlled ion release from the boron-modified glass network. This work establishes a clear structure–surface–bioactivity relationship and provides a simple yet effective strategy to activate bioinert glass–ceramics for bone-related applications.